NO985807D0 - Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament - Google Patents
Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikamentInfo
- Publication number
- NO985807D0 NO985807D0 NO985807A NO985807A NO985807D0 NO 985807 D0 NO985807 D0 NO 985807D0 NO 985807 A NO985807 A NO 985807A NO 985807 A NO985807 A NO 985807A NO 985807 D0 NO985807 D0 NO 985807D0
- Authority
- NO
- Norway
- Prior art keywords
- drug
- active ingredients
- preparation process
- systems containing
- separate sections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9607209A FR2749514B1 (fr) | 1996-06-11 | 1996-06-11 | Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament |
PCT/FR1997/001024 WO1997047305A1 (fr) | 1996-06-11 | 1997-06-10 | Systemes transdermiques renfermant deux principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament |
Publications (3)
Publication Number | Publication Date |
---|---|
NO985807D0 true NO985807D0 (no) | 1998-12-11 |
NO985807L NO985807L (no) | 1999-02-10 |
NO320999B1 NO320999B1 (no) | 2006-02-27 |
Family
ID=9492920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19985807A NO320999B1 (no) | 1996-06-11 | 1998-12-11 | Anordning for transdermal administrering av 2 aktive ingredienser i separate seksjoner og dens fremstillingsprosess. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0904086B1 (no) |
JP (1) | JP2000511921A (no) |
CN (1) | CN1119150C (no) |
AR (1) | AR008229A1 (no) |
AT (1) | ATE284215T1 (no) |
AU (1) | AU739141B2 (no) |
BR (1) | BR9715082A (no) |
CA (1) | CA2257913A1 (no) |
CZ (1) | CZ295350B6 (no) |
DE (1) | DE69731883T2 (no) |
ES (1) | ES2235236T3 (no) |
FR (1) | FR2749514B1 (no) |
NO (1) | NO320999B1 (no) |
PL (1) | PL189361B1 (no) |
RU (1) | RU2209090C2 (no) |
TR (1) | TR199802577T2 (no) |
TW (1) | TWI228999B (no) |
WO (1) | WO1997047305A1 (no) |
ZA (1) | ZA975160B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200306196A (en) * | 2002-04-03 | 2003-11-16 | Wyeth Corp | Hormone replacement therapy |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
EP2289486A1 (en) | 2005-12-27 | 2011-03-02 | Teva Women's Health, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
US10821297B2 (en) * | 2016-09-30 | 2020-11-03 | Johnson & Johnson Consumer Inc. | Kit and method for topical delivery of benefits |
JP6982960B2 (ja) * | 2017-02-07 | 2021-12-17 | リンテック株式会社 | 包材および包装体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2430953A1 (fr) * | 1978-07-13 | 1980-02-08 | Roussel Uclaf | Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments |
DE3714140A1 (de) * | 1987-04-28 | 1988-11-10 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
-
1996
- 1996-06-11 FR FR9607209A patent/FR2749514B1/fr not_active Expired - Fee Related
-
1997
- 1997-06-10 AT AT97928318T patent/ATE284215T1/de not_active IP Right Cessation
- 1997-06-10 DE DE69731883T patent/DE69731883T2/de not_active Expired - Fee Related
- 1997-06-10 BR BR9715082-7A patent/BR9715082A/pt not_active IP Right Cessation
- 1997-06-10 CZ CZ19984108A patent/CZ295350B6/cs not_active IP Right Cessation
- 1997-06-10 PL PL97330597A patent/PL189361B1/pl not_active IP Right Cessation
- 1997-06-10 AU AU32661/97A patent/AU739141B2/en not_active Ceased
- 1997-06-10 CN CN97197162A patent/CN1119150C/zh not_active Expired - Fee Related
- 1997-06-10 EP EP97928318A patent/EP0904086B1/fr not_active Expired - Lifetime
- 1997-06-10 AR ARP970102528A patent/AR008229A1/es active IP Right Grant
- 1997-06-10 CA CA002257913A patent/CA2257913A1/fr not_active Abandoned
- 1997-06-10 TR TR1998/02577T patent/TR199802577T2/xx unknown
- 1997-06-10 RU RU99100390/14A patent/RU2209090C2/ru not_active IP Right Cessation
- 1997-06-10 JP JP10501289A patent/JP2000511921A/ja not_active Abandoned
- 1997-06-10 WO PCT/FR1997/001024 patent/WO1997047305A1/fr active IP Right Grant
- 1997-06-10 ES ES97928318T patent/ES2235236T3/es not_active Expired - Lifetime
- 1997-06-11 ZA ZA9705160A patent/ZA975160B/xx unknown
- 1997-06-16 TW TW086108355A patent/TWI228999B/zh not_active IP Right Cessation
-
1998
- 1998-12-11 NO NO19985807A patent/NO320999B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO320999B1 (no) | 2006-02-27 |
ZA975160B (en) | 1998-06-11 |
AU3266197A (en) | 1998-01-07 |
CZ410898A3 (cs) | 1999-09-15 |
TR199802577T2 (xx) | 1999-03-22 |
TWI228999B (en) | 2005-03-11 |
CN1119150C (zh) | 2003-08-27 |
CN1227492A (zh) | 1999-09-01 |
FR2749514B1 (fr) | 1998-08-07 |
NO985807L (no) | 1999-02-10 |
JP2000511921A (ja) | 2000-09-12 |
PL330597A1 (en) | 1999-05-24 |
EP0904086A1 (fr) | 1999-03-31 |
ES2235236T3 (es) | 2005-07-01 |
FR2749514A1 (fr) | 1997-12-12 |
EP0904086B1 (fr) | 2004-12-08 |
AR008229A1 (es) | 1999-12-29 |
WO1997047305A1 (fr) | 1997-12-18 |
CA2257913A1 (fr) | 1997-12-18 |
DE69731883T2 (de) | 2005-12-22 |
CZ295350B6 (cs) | 2005-07-13 |
BR9715082A (pt) | 2003-07-15 |
ATE284215T1 (de) | 2004-12-15 |
AU739141B2 (en) | 2001-10-04 |
RU2209090C2 (ru) | 2003-07-27 |
PL189361B1 (pl) | 2005-07-29 |
DE69731883D1 (de) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1538160T3 (da) | Substituerede isochinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel | |
NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
NO933434D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
NO975513D0 (no) | 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel | |
NO20004353L (no) | Nye pyridazinderivater og medikamenter inneholdende disse som aktive ingredienser | |
DK0854880T3 (da) | Derivater af 5-O-desosaminyl-6-O-methyl-erythronolid A, fremgangsmåde til deres fremstilling og deres anvendelse til fremstilling af biologisk aktive produkter | |
DK267489A (da) | 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler | |
EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
NO992408D0 (no) | FremgangsmÕte for lavavfalls fremstilling av skiveformige formlegemer inneholdende aktive ingredienser, og transdermale terapeutiske systemer inneholdende samme | |
NO981522L (no) | Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister | |
DK146786D0 (da) | 4'-demethyl-4-epipodophyllotoxinderivater, deres fremstilling og anvendelse i laegemidler, isaer som antitumormidler | |
NO975020D0 (no) | Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi | |
NO985807D0 (no) | Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament | |
NO951418D0 (no) | Peptidderivater, deres fremstilling og anvendelse som terapeutika | |
NO20001288L (no) | Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel | |
DK60893D0 (da) | Piperidinderivater, deres fremstilling og anvendelse | |
NO933435D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
FI953956A (fi) | 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
FI941912A0 (fi) | 3-kinolyylillä substituoidut dihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
NO974057L (no) | Bisykliske takykinin-antagonister, fremstilling derav og deres anvendelse i farmasöytisk sammensetning | |
DK0763535T3 (da) | Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser | |
NO900926L (no) | Substituerte (kinolin-2-yl-metoksy)fenyl-n,n'-sulfonylurinstoffer, deres fremstilling og anvendelse i legemidler. | |
DK619989D0 (da) | Dipeptidderivater, deres fremstilling og anvendelse som laegemidler | |
DK489889A (da) | Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler | |
DK648389A (da) | Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler |